Naidoo J, Peters S, Runglodvatana Y, Li JY, et al. Domvanalimab combined with zimberelimab as first-line treatment in patients with PD-L1-high, advanced non-small cell lung cancer: Results from the randomized phase 2 ARC-10 study, Part1. Lung Cancer 2026;215:109316.
PMID: 41830668